Papers
22
Total Citations
437
H-Index
11
About
Thomas J. Maatman is a urologic surgeon and researcher whose work has significantly advanced the field of minimally invasive and robotic urological surgery. His research spans two primary domains: robot-assisted radical cystectomy (RARC) for bladder cancer and robot-assisted radical prostatectomy (RALP), with a particular focus on optimizing surgical technique and perioperative outcomes. Maatman has been a prominent contributor to the International Robotic Cystectomy Consortium (IRCC), a collaborative database that has enabled large-scale investigation of robotic bladder cancer surgery. His studies have addressed critical clinical questions, including the comparative merits of intracorporeal versus extracorporeal urinary diversion (89 citations), early oncologic failure rates following RARC (57 citations), and the safety of neoadjuvant chemotherapy in this setting. These contributions have helped shape evidence-based practice for one of urology's most complex operations. In prostate cancer surgery, Maatman has championed the use of low-pressure pneumoperitoneum during RALP, demonstrating reductions in postoperative ileus through both retrospective and prospective randomized trials. His early work examining surgical margin quality during robotic prostatectomy program initiation (60 citations) also raised important questions about patient safety during institutional learning curves. Collectively, his research has earned over 350 citations, reflecting meaningful influence on surgical oncology practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10